Infimer (Israel) Today

INFR Stock  ILA 60.40  0.00  0.00%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 23

 
High
 
Low
Low
Infimer is trading at 60.40 as of the 25th of April 2024, a No Change since the beginning of the trading day. The stock's open price was 60.4. Infimer has about a 23 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Infimer are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Infimer Ltd develops technology and production processes for converting municipal solid waste. The company was founded in 2013 and is based in Avihayil, Israel. INFIMER operates under Waste Management classification in Israel and is traded on Tel Aviv Stock Exchange. The company has 1.06 M outstanding shares. More on Infimer

Moving against Infimer Stock

  0.57FORTY FormulaPairCorr
  0.44TIGBUR Tigbur TemporaryPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Infimer Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Infimer's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Infimer or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chief Executive OfficerMoshe Dayan
Business ConcentrationMaterials, Chemicals, Waste Management, Industrials (View all Sectors)
Infimer (INFR) is traded on Tel Aviv Stock Exchange in Israel and employs 23,700 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Infimer's market, we take the total number of its shares issued and multiply it by Infimer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Infimer operates under Chemicals sector and is part of Materials industry. The entity has 1.06 M outstanding shares. Infimer has accumulated about 14 K in cash with (1.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Infimer Probability Of Bankruptcy
Ownership Allocation
The market capitalization of Infimer is 17.99 Million. Infimer retains 14.32 (percent) of its outstanding shares held by insiders and 10.35 (percent) owned by outside corporations. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Infimer Ownership Details

Infimer Stock Price Odds Analysis

What are Infimer's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Infimer jumping above the current price in 90 days from now is about 75.46%. The Infimer probability density function shows the probability of Infimer stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Infimer has a beta of 0.8202. This usually indicates as returns on the market go up, Infimer average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Infimer will be expected to be much smaller as well. Additionally, infimer has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 60.4HorizonTargetOdds Above 60.4
24.45%90 days
 60.40 
75.46%
Based on a normal probability distribution, the odds of Infimer to move above the current price in 90 days from now is about 75.46 (This Infimer probability density function shows the probability of Infimer Stock to fall within a particular range of prices over 90 days) .

Infimer Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Infimer market risk premium is the additional return an investor will receive from holding Infimer long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Infimer. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Infimer's alpha and beta are two of the key measurements used to evaluate Infimer's performance over the market, the standard measures of volatility play an important role as well.

Infimer Stock Against Markets

Picking the right benchmark for Infimer stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Infimer stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Infimer is critical whether you are bullish or bearish towards Infimer at a given time. Please also check how Infimer's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infimer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Infimer Corporate Directors

Infimer corporate directors refer to members of an Infimer board of directors. The board of directors generally takes responsibility for the Infimer's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Infimer's board members must vote for the resolution. The Infimer board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Asaf TennenbaumExternal DirectorProfile
Shirley BeharExternal DirectorProfile
Hadas GelanderExternal DirectorProfile
Tal TamirDirectorProfile

How to buy Infimer Stock?

Before investing in Infimer, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Infimer. To buy Infimer stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Infimer. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Infimer stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Infimer stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Infimer stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Infimer, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Infimer?

The danger of trading Infimer is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Infimer is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Infimer. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Infimer is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Infimer. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Infimer Stock analysis

When running Infimer's price analysis, check to measure Infimer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infimer is operating at the current time. Most of Infimer's value examination focuses on studying past and present price action to predict the probability of Infimer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infimer's price. Additionally, you may evaluate how the addition of Infimer to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Global Correlations
Find global opportunities by holding instruments from different markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Please note, there is a significant difference between Infimer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Infimer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infimer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.